Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification

Hepatology

Volumn 53, Issue 4, 2011, Pages 1182-1191

  Ronot, Maxime ^a,b   Bahrami, Stephane ^c   Calderaro, Julien ^a   Valla, Dominique Charles ^a,b   Bedossa, Pierre ^a,b   Belghti, Jacques ^a   Vilgrain, Valérie ^a,b   Paradis, Valérie ^a,b  

^a BEAUJON HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DRUG SCREENING; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIVER ADENOMA; LIVER BIOPSY; LIVER SURGERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; BIOPSY; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; RETROSPECTIVE STUDIES;

EID: 79953736547     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24147     Document Type: Article

References (21)

1. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48: 163-170.
2. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995; 19: 13-18.
3. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21: 983-990; discussion 990-981.
4. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. HEPATOLOGY 2007; 46: 740-748.
5. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. HEPATOLOGY 2006; 43: 515-524.
6. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. HEPATOLOGY 2009; 50: 481-489.
7. Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128: 1211-1218.
8. Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. HEPATOLOGY 2002; 36: 927-935.
9. Paradis V, Benzekri A, Dargere D, Bieche I, Laurendeau I, Vilgrain V, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004; 126: 1323-1329.
10. Paradis V, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. HEPATOLOGY 2007; 46: 140-146.
11. Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457: 200-204.
12. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-1705.
13. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. HEPATOLOGY 2009; 50: 481-489.
14. Monga SP. Hepatic adenomas: presumed innocent until proven to be beta-catenin mutated. HEPATOLOGY 2006; 43: 401-404.
15. Van der Borght S, Libbrecht L, Katoonizadeh A, Aerts R, Nevens F, Verslype C, et al. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 2007; 51: 855-856.
16. Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011; 60: 85-89.
17. Arrive L, Flejou JF, Vilgrain V, Belghiti J, Najmark D, Zins M, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994; 193: 507-512.
18. Brancatelli G, Federle MP, Vullierme MP, Lagalla R, Midiri M, Vilgrain V. CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 2006; 30: 745-750.
19. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 1995; 165: 303-308.
20. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. HEPATOLOGY 2008; 48: 808-818.
21. Lewin M, Handra-Luca A, Arrive L, Wendum D, Paradis V, Bridel E, et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 2006; 241: 433-440.